Ownership history in CAXTON CORP · 4 quarters on record
This page tracks every 13F SEC filing in which CAXTON CORP reported a position in SAB BIOTHERAPEUTICS INC (SABS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 10,527 | -408 | -3.7% | 0.92% | $39K | $3.74 |
| 2025 Q3 | ADDED | 10,935 | +408 | +3.9% | 0.10% | $22K | $2.01 |
| 2013 Q1 | UNCHANGED | 10,527 | — | 0% | 0.92% | $39K | — |
| 2012 Q4 | INITIATED | 10,527 | — | — | 0.92% | $39K | — |
As of 2025 Q4 — sorted by position size